MedScrub vs ThetaRho (2026)

AI Health Index verifiedAugust 4, 2026
Verdict

Two infrastructure plays in clinical intelligence with different obsessions. MedScrub inverts the normal arrangement: rather than sending patient records to a model, it strips the patient out first, sends de identified content to whichever model the customer chooses, and re identifies the answer on the way back. That is the strongest privacy architecture in this category and it also answers the model provenance question completely, since the customer picks the model. ThetaRho sells the stack in three separable layers, normalisation across named record systems and exchanges, an intelligence layer, and applications on top, so a buyer takes only the part they are missing. MedScrub is the answer when the obstacle is legal rather than technical. ThetaRho is the answer when the obstacle is that the data was never usable in the first place.

The case for MedScrub
  • The privacy architecture is the strongest in this category and it is structural: the patient is stripped out before anything reaches a model and re identified only on the way back, so the model provider never sees identified data.
  • It answers the whose model is it question more completely than anything else in this index, because the customer chooses the model rather than inheriting the vendor's.
  • For an organisation whose blocker is sending patient records to a third party model, this removes the blocker rather than papering over it with a contract.
The case for ThetaRho
  • It sells three separated layers, normalisation, intelligence and application, and will sell any of them, so a buyer takes only the part they lack.
  • Four record systems are named explicitly alongside the national exchange networks, wearables and monitoring feeds, so the normalisation layer covers where the data actually lives.
  • It names the models it runs on, which is a governance disclosure in itself and lets a buyer reason about the supply chain.

This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. MedScrub and ThetaRho are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded

At a Glance

Plain facts

Fact MedScrub ThetaRho
Primary category Clinical Summarization & Chart Review Clinical Summarization & Chart Review
Website medscrub.ai thetarho.ai
Attribute Matrix

Side by Side

Axis
M
MedScrub
T
ThetaRho
AI Centrality
Autonomy and Oversight Model
Model and Technology Transparency
Model Supply Chain Disclosure
Clinical and Operational Evidence
AI Safety and PHI Stewardship
HIPAA and BAA Posture
Security Certifications and Trust Center
FDA and Regulatory Status
AI Governance and Bias Disclosure
AI Liability and Recourse
EHR and Interoperability Depth
Deployment Model and Data Residency
Commercial Transparency
Setting and Specialty Coverage
Citable Summaries

Each record in one paragraph

Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.

MedScrub

The AI Health Index awards MedScrub its top capability grade on Model Supply Chain Disclosure, AI Safety and PHI Stewardship and Deployment Model and Data Residency. Set against ThetaRho, MedScrub grades higher on Model Supply Chain Disclosure, AI Safety and PHI Stewardship and Deployment Model and Data Residency. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.

Source: AI Health Index, August 2026

ThetaRho

The AI Health Index awards ThetaRho its top capability grade on AI Centrality. Set against MedScrub, ThetaRho grades higher on several axes, including AI Centrality, Autonomy and Oversight Model and HIPAA and BAA Posture. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.

Source: AI Health Index, August 2026

FAQ

Questions buyers ask

Should we choose MedScrub or ThetaRho?

On the axes where the AI Health Index separates them, MedScrub grades higher on Model Supply Chain Disclosure, AI Safety and PHI Stewardship and Deployment Model and Data Residency, and ThetaRho grades higher on several axes, including AI Centrality, Autonomy and Oversight Model and HIPAA and BAA Posture. ThetaRho leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.

Where do MedScrub and ThetaRho differ most?

The widest separation the AI Health Index records between MedScrub and ThetaRho is on AI Safety and PHI Stewardship, where MedScrub grades A and ThetaRho grades C. That axis sits in the AI Capability group, so it should carry the most weight for a buyer whose binding constraint is how much of the work the model itself is trusted to do.

Where do MedScrub and ThetaRho grade the same?

The AI Health Index grades MedScrub and ThetaRho the same on several axes, including Model and Technology Transparency, Clinical and Operational Evidence and Security Certifications and Trust Center. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.

Keep Comparing

Related comparisons

Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Summarization & Chart Review page.

Disclosure

Neither vendor publishes an accuracy or completeness figure, an independent evaluation or a named deployment with a measured result, so a pilot is the only evidence available on either side. MedScrub describes no oversight mechanism for the clinical output, no confidence signal and no abstention behaviour, which is a notable gap alongside an otherwise exceptional privacy design, and de identification is never perfect: the residual re identification risk in free text is real and neither the vendor nor the buyer can eliminate it. Neither publishes a security attestation, retention position or pricing.